Tag: Psoriasis
Factors Linked to Development of Pediatric Psoriasis Identified
Factors independently linked to development include atopic dermatitis, family history of psoriasis, skin and fungal infections
Papers on COVID-19 in Psoriasis, Psoriatic Arthritis Carry Risk for Bias
Risk for bias high in papers relating to patients with psoriasis and psoriatic arthritis receiving biologic therapies
Risk for Psoriasis Increased for Cancer Survivors
Increased risks seen for survivors of leukemia, lymphoma, multiple myeloma, skin cancer, and lung cancer in subgroup analyses
Questionnaire Responses About Dermatology History Inconsistent
History of psoriasis consistently reported, whereas history of atopic dermatitis is not
Prevalence of Psoriasis 3 Percent in U.S. Population Age 20+
Prevalence similar for women and men, highest among Whites, not significantly different from 2003
Inflammation at IP Thumb Joint Common in Psoriatic Arthritis
Risk of MRI global inflammation around thumb IP joint higher than in patients with undifferentiated inflammatory arthritis
Adults With Psoriasis More Likely to Have Rheumatoid Arthritis
Subgroup analysis by age shows point estimate higher for adults aged 20 to 49 years than for those aged 50 years and older
Higher BMI Linked to Increased Risk for Developing Psoriasis
Hazard ratio increased for overweight, obese class 1, obese class 2/3 compared with those with BMI <25.0 kg/m2
More Body Surface Area Clearance With Psoriasis Tied to Better Quality of Life
Findings consistent at both six and 12 months of treatment with systemic therapy
Bimekizumab Tops Secukinumab for Plaque Psoriasis
In second study, bimekizumab showed noninferiority and superiority to adalimumab for moderate-to-severe disease
